Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

Conclusions The results suggest that treatment with IDeg reduces GV, A1c levels and the incidence of global and nocturnal hypoglycemia events in patients with HGV, but not in patients with low GV.
Source: Journal of Clinical and Translational Endocrinology - Category: Endocrinology Source Type: research